Cutaneous sarcoidosis due to immune‐checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor

• Main Authors: J. P. Pham (Author), P. Star (Author), S. Wong (Author), D. L. Damian (Author), R. P. M. Saw (Author), M. J. Whitfeld (Author), A. M. Menzies (Author), A. M. Joshua (Author), A. Smith (Author)
• Format: Book
• Published: Wiley, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Sarcoidosis is a non‐infective granulomatous disorder of unknown aetiology, with cutaneous involvement affecting up to 30% of patients. Drug‐induced sarcoidosis has been reported secondary to modern melanoma therapies including immune‐checkpoint inhibitors and first generation BRAF inhibito...